Ellington Management Group’s BioTelemetry, Inc. BEAT Stock Holding History

Ellington Management Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,716	Closed	-$229K	–	986
2015 Q3	$229K	Sell	18,716 -3,190	-15%	-$40.7K	0.06%	518
2015 Q2	$207K	Buy	+21,906	New	+$203K	0.05%	585
2015 Q1	–	Sell	-20,300	Closed	-$204K	–	955
2014 Q4	$204K	Buy	+20,300	New	+$174K	0.07%	454
2014 Q2	–	Sell	-11,600	Closed	-$117K	–	820
2014 Q1	$117K	Buy	+11,600	New	+$107K	0.03%	567
2013 Q4	–	Sell	-30,600	Closed	-$303K	–	994
2013 Q3	$303K	Buy	+30,600	New	+$241K	0.06%	515

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAD

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ellington Management Group's BEAT Position: Q4 2015 in Review

Ellington Management Group sold out of BioTelemetry, Inc. (BEAT) in Q4 2015, closing a stake of 18,716 shares — an estimated $229K sold.

Ellington Management Group first reported a position in BEAT in Q3 2013 and held it in 5 quarters. The position peaked at $303K in Q3 2013. 115 funds tracked by Wall St. Rank hold BEAT as of Q4 2015.

Ellington Management Group reported no remaining BioTelemetry, Inc. position as of Q4 2015 after selling out during the quarter.
Ellington Management Group sold 18,716 BioTelemetry, Inc. shares in Q4 2015, an estimated $229K.
Ellington Management Group first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 5 quarters.
Ellington Management Group's BioTelemetry, Inc. position peaked at $303K in Q3 2013.
115 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2015.

Based on Ellington Management Group's 13F filing for Q4 2015, filed 16 Feb 2016.